Mehmet Oz voiced his support for the use of GLP-1 (glucagon-like peptide-1) medications, such as Ozempic, for appropriate uses
The most effective long-term strategy is not always about choosing the medication associated with the highest average weight loss in a study
We hope that this high-quality medicine will benefit the Chinese patients as soon as possible, and provide personalized treatment plans for different degrees of obesity." The published results were from the first part of a randomized, double-blind, placebo-controlled Phase 2 trial (ClinicalTrials.gov, NCT04904913, part 1 evaluated mazdutide 3mg, 4.5mg and 6mg, part 2 evaluated mazdutide 9mg)
Miller A et al
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) affects millions of people worldwide
Theres some evidence that losing weight too quickly can have some downsides, so slowing it down might help you maintain it later on